Latest data from May 6, 2022
Number of Health Center respondents = 37 (82% of all Health Centers)
Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.
Patients Tested
| Metrics | Value |
|---|---|
| Patients Tested for COVID-19, Virus Detection (PCR, Antigen)1 | 7,616 |
| Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, Antigen) | 83.43% |
| Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen)1 | 952 |
| Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen) | 79.26% |
Patients by Race and Ethnicity
| Race/Ethnicity | Patients Tested, Virus Detection (PCR, Antigen)2 | Patients Tested Positive, Virus Detection (PCR, Antigen)2 |
|---|---|---|
| White, Non-Hispanic/Latino Patients | 14.57% | 14.08% |
| White, Hispanic/Latino Patients | 33.59% | 23.32% |
| Black/African American, Non-Hispanic/Latino Patients | 18.76% | 12.50% |
| Black/African American, Hispanic/Latino Patients | 0.60% | 0.63% |
| Asian Patients3 | 2.61% | 2.42% |
| American Indian/Alaska Native Patients3 | 0.74% | 1.58% |
| Native Hawaiian/Other Pacific Islander Patients3 | 0.17% | 0.00% |
| Patients with More Than One Race3 | 1.21% | 3.15% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 15.72% | 10.19% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 2.48% | 2.84% |
| Unreported/Refused to Report Race and Ethnicity | 9.55% | 29.31% |
Patients Vaccinated
| Metrics | Value |
|---|---|
| COVID-19 Immunization Series Initiated | 913 |
| Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization | 82.27% |
| COVID-19 Immunization Series Completed | 908 |
| Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization | 85.07% |
| COVID-19 Immunization Series Additional | 3,241 |
| Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine | 77.99% |
Vaccinations by Race and Ethnicity
| Race/Ethnicity | Patient COVID-19 Immunization Series Initiated2 | Patient COVID-19 Immunization Series Completed2 | Patient COVID-19 Immunization Series Additional2 |
|---|---|---|---|
| White, Non-Hispanic/Latino Patients | 16.10% | 13.55% | 19.99% |
| White, Hispanic/Latino Patients | 25.52% | 27.97% | 25.24% |
| Black/African American, Non-Hispanic/Latino Patients | 27.60% | 26.54% | 24.13% |
| Black/African American, Hispanic/Latino Patients | 0.33% | 0.66% | 0.34% |
| Asian Patients3 | 0.99% | 1.32% | 2.56% |
| American Indian/Alaska Native Patients3 | 2.08% | 0.88% | 1.60% |
| Native Hawaiian/Other Pacific Islander Patients3 | 0.11% | 0.11% | 0.46% |
| Patients with More Than One Race3 | 1.20% | 1.76% | 2.04% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 16.87% | 17.95% | 14.47% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 2.30% | 2.09% | 1.97% |
| Unreported/Refused to Report Race and Ethnicity | 6.90% | 7.16% | 7.19% |
Testing Logistics
Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, Antigen)
| Metrics | Value |
|---|---|
| Less Than 1 Hour | 8.11% |
| 1 to 24 Hours | 40.54% |
| More Than 24 Hours | 51.35% |
| N/A | 0.00% |
Vaccine Logistics
Challenges in Deploying the COVID Vaccine
| Metrics | Value |
|---|---|
| Financial reimbursement for costs associated with vaccine administration | 5.41% |
| Staffing to administer the vaccine | 21.62% |
| Vaccine confidence | 35.14% |
| Vaccine storage capacity | 2.70% |
| Vaccine supply | 2.70% |
| Other | 8.11% |
| None | 40.54% |
Operations and Staff
| Metrics | Value |
|---|---|
| COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program | 13.51% |
| Average Percent of Health Center Visits Conducted Virtually | 15.81% |
Mobile Vans, Pop-Up Clinics, and School-Based Sites
| Metrics | Value |
|---|---|
| Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics | 27.03% |
| Number of Mobile Van Sites | 8 |
| Number of Pop-up Clinics | 21 |
| Number of School-Based Vaccination Sites | 7 |
| Number of Family Vaccination Clinics | 8 |
Monoclonal Antibody Therapy
Methods in Providing Access to Monoclonal Antibody Therapy
| Metrics | Value |
|---|---|
| Direct provision of monoclonal antibody therapies | 2.70% |
| Refer patients to another organization that provides monoclonal antibody therapies | 51.35% |
| None | 45.95% |
Challenges in Providing Access to Monoclonal Antibody Therapy
| Metrics | Value |
|---|---|
| Access to therapeutics | 2.70% |
| Patient awareness/education | 8.11% |
| Staffing capacity | 21.62% |
| Therapy administration/onsite logistics | 21.62% |
| Other | 5.41% |
| None | 54.05% |
Test Kit Distribution
| Metrics | Value |
|---|---|
| Number of Health Centers that Distributed Test Kits Received through the HRSA COVID-19 Testing Supply Program | 29 |
| Number of Test Kits Distributed through the HRSA COVID-19 Testing Supply Program | 13,289 |
Test Kit Distribution Methods4
| Metrics | Value |
|---|---|
| Provided to Existing Health Center Patients | 89.66% |
| Provided to General Public Who Came to the Health Center | 65.52% |
| Provided at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) | 24.14% |
| Provided at Other Community Events | 17.24% |
| Provided to migratory/seasonal agricultural workers directly or through partnerships with community organizations serving these individuals | 6.90% |
| Provided to individuals with limited English proficiency directly or through partnerships with community organizations serving these individuals | 17.24% |
| Provided to older adults and/or individuals with disabilities directly or through partnerships with community organizations serving these individuals | 10.34% |
| Provided to school-age children and/or their families directly or through partnerships with schools | 20.69% |
| Provided to individuals living in HUD-assisted housing and/or individuals experiencing homelessness directly or through partnerships with local housing authorities | 6.90% |
| Other | 6.90% |
N95 Mask Distribution
| Metrics | Value |
|---|---|
| Health Centers that Distributed N95 Masks Received through the HRSA Health Center COVID-19 N95 Mask Program | 24 |
| Number of N95 Masks Distributed through the HRSA Health Center COVID-19 N95 Mask Program | 30,349 |
N95 Mask Distribution Methods5
| Metrics | Value |
|---|---|
| Provided to Existing Health Center Patients | 83.33% |
| Provided to General Public Who Came to the Health Center | 75.00% |
| Provided at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) | 25.00% |
| Provided at Other Community Events | 25.00% |
| Provided to migratory/seasonal agricultural workers directly or through partnerships with community organizations serving these individuals | 8.33% |
| Provided to individuals with limited English proficiency directly or through partnerships with community organizations serving these individuals | 16.67% |
| Provided to older adults and/or individuals with disabilities directly or through partnerships with community organizations serving these individuals | 12.50% |
| Provided to school-age children and/or their families directly or through partnerships with schools | 16.67% |
| Provided to individuals living in HUD-assisted housing and/or individuals experiencing homelessness directly or through partnerships with local housing authorities | 8.33% |
| Other | 12.50% |
Oral Antiviral Medication Distribution
| Metrics | Value |
|---|---|
| Number of Health Centers that Provided COVID-19 Oral Antiviral Medication through the HRSA Health Center COVID-19 Therapeutics Program | 8 |
| Racial and/or Ethnic Minority Patients Who Received COVID-19 Oral Antiviral Medication | 66.04% |
Oral Antiviral Medication Distribution by Race and Ethnicity
| Race/Ethnicity | Value |
|---|---|
| White, Non-Hispanic/Latino Patients | 22.64% |
| White, Hispanic/Latino Patients | 28.30% |
| Black/African American, Non-Hispanic/Latino Patients | 15.09% |
| Black/African American, Hispanic/Latino Patients | 0.00% |
| Asian Patients3 | 3.77% |
| American Indian/Alaska Native Patients3 | 3.77% |
| Native Hawaiian/Other Pacific Islander Patients3 | 0.00% |
| Patients with More Than One Race3 | 1.89% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 13.21% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 3.77% |
| Unreported/Refused to Report Race and Ethnicity | 7.55% |
Oral Antiviral Medication Distribution by Population Type
| Metrics | Value |
|---|---|
| Migratory/Agricultural Workers | 0.00% |
| Patients Experiencing Homelessness | 13.21% |
| Patients Who Are Residents of Public Housing | 0.00% |
| Patients with Limited English Proficiency | 24.53% |
| Children Under 18 Years of Age | 1.89% |
1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.
2 Percentages may not add to 100% due to rounding to the hundredths.
3 Includes Hispanic/Latino and Non-Hispanic/Latino.
4 Percentages are calculated using the number of health centers that have distributed test kits received through the HRSA COVID-19 Testing Supply Program as the denominator.
5 Percentages are calculated using the number of health centers that have distributed N95 masks received through the HRSA Health Center COVID-19 N95 Mask Program as the denominator.
Date Last Reviewed: